Kneu Health Expands Leadership Team to Enhance Neurodegenerative Care Across the U.S.

Kneu Health Expands Leadership Team to Scale Neurodegenerative Care

In a significant move to enhance its operations and widen the reach of its services, Kneu Health, a precision neurology platform focusing on Parkinson's disease and dementia care, has announced the recruitment of top professionals to its leadership team. This strategic addition aims to scale the deployment of neurodegenerative care across health systems in the United States.

New Appointments
The company has appointed Jo Lim as the U.S. General Manager, where she will lead the deployment and customer operations of Kneu’s innovative platform. Lim comes with extensive experience in scaling healthcare organizations, having previously worked with Vim and Babylon Health where she played a crucial role in U.S. expansion initiatives. Alongside her, Dr. Matea Deliu has joined Kneu as the Director of Partnerships and System Transformation. Dr. Deliu's expertise in digital transformation and integrated care systems will be pivotal in driving clinical and system-level adoption of Kneu's services.

Furthermore, Hanson Chow has been promoted to Chief Technology Officer, a role he steps into having successfully led Kneu’s platform and regulatory strategies. Divya Mattoo is also brought aboard as the Head of Growth, where she will focus on enhancing go-to-market and growth strategies for the company.

Advancing Neurodegenerative Care
Kneu Health's leadership expansion aligns with the company’s vision to provide continuous neurological care to individuals affected by degenerative diseases. The announcements come on the heels of a pivotal year characterized by significant milestones, including FDA approval for a smartphone-based device that measures Parkinson's tremors and the initiation of pilot programs at major healthcare institutions like Cedars-Sinai and Mass General Brigham.

The data collected from over 1,400 users across U.S. and UK NHS deployments has been foundational to Kneu’s clinically validated platform. It powers the analysis and predictive biomarker generation through monitoring patients’ speech, movement, and cognition. This technology allows clinicians to detect changes in patient conditions earlier, improving intervention strategies within existing healthcare frameworks.

Building on Research and Experience
Backed by more than a decade of longitudinal studies conducted by Oxford University, Kneu Health's platform is designed to transform everyday interactions with patients into meaningful clinical insights. Their approach focuses on streamlining the care process and addressing existing gaps often seen in traditional care models, where patients may only see specialists infrequently.

Parkinson's disease currently affects over one million Americans, and with projections indicating a sharp increase in prevalence, Kneu's model of continuous monitoring is timely and essential. By providing healthcare systems with tools that support regular monitoring, clinicians can more effectively manage their patients’ health, fostering a more proactive approach to care. The NHS's favorable pilot results have shown improved efficiency and reduced emergency admissions, showcasing the potential impact of this innovative platform.

CEO Caroline Cake reflects, "As healthcare organizations aim to operationalize continuous neurological monitoring, Kneu Health's enhanced leadership can support the broader integration of these services into everyday practice. By engaging patients in their care, we can improve health outcomes significantly."

In summary, Kneu Health is positioning itself as a leader in the neurodegenerative care space, employing advanced technology and a robust leadership team to ensure that patients receive the continuous care they need. With a foundation built on solid research and proactive technological innovation, the future looks promising for individuals living with neurological disorders.

For additional information about Kneu Health and its offerings, visit Kneu Health.

Media Contact:
Kneu Health
[email protected]

Source: Kneu Health